Detalles de la búsqueda
1.
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
Ann Surg
; 278(1): 127-134, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833413
2.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol
; 23(10): 1274-1286, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108662
3.
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis.
Cancer
; 128(15): 2932-2938, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561319
4.
Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trial.
Cancer
; 128(14): 2796-2805, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536104
5.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 643-654, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857412
6.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 655-664, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857414
7.
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
N Engl J Med
; 378(19): 1789-1801, 2018 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658430
8.
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 21(10): 1366-1377, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32941794
9.
Impact of acute kidney injury on anticancer treatment dosage and long-term outcomes: a pooled analysis of European Organisation for Research and Treatment of Cancer trials.
Nephrol Dial Transplant
; 2020 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32337562
10.
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
BMC Cancer
; 19(1): 494, 2019 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126258
11.
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Int J Cancer
; 142(12): 2610-2620, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383713
12.
Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.
Oncologist
; 23(10): 1250-1259, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650688
13.
Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.
Oncology
; 90(1): 21-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26468947
14.
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Lancet Oncol
; 16(1): 76-86, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25498218
15.
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Cancer
; 121(17): 2933-41, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033286
16.
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial.
Eur J Nucl Med Mol Imaging
; 42(6): 848-57, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25711176
17.
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Lancet Oncol
; 15(4): 415-23, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24618336
18.
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 379(9829): 1879-86, 2012 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22595799
19.
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Lancet Oncol
; 13(10): 1045-54, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22954508
20.
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
Lancet Oncol
; 12(11): 1045-52, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21937277